Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan

Low Urin Tract Symptoms. 2024 Jan;16(1):e12508. doi: 10.1111/luts.12508. Epub 2023 Nov 21.

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease characterized by bladder pain, frequency, and nocturia. The most common pathologies include chronic inflammation and bladder urothelium dysfunction. According to the bladder condition with or without Hunner's lesions, IC/BPS can be divided into "IC" in patients with Hunner's lesion (HIC) and "BPS" in those without Hunner's lesion (NHIC). Previous studies have reported greater central sensitization and interorgan cross-talk in patients with NHIC. Multimodal treatments have been recommended in clinical guidelines under the biopsychosocial model. The bladder-gut-brain axis has also been speculated, and multimodal therapies are necessary. Unfortunately, currently, no treatment has been reported durable for IC/BPS. Patients with IC/BPS usually experience anxiety, depression, holistic physical responses, and even threats to social support systems. The lack of durable treatment outcomes might result from inadequate diagnostic accuracy and differentiation of clinical phenotypes based on the underlying pathophysiology. Precision assessment and treatment are essential for optimal therapy under definite IC/BPS phenotype. This article reviewed currently available literature and proposed a diagnosis and treatment algorithm. Based on bladder therapy combined with suitable physical and psychological therapies, a well-grounded multimodal therapy and treatment algorithm for IC/BPS following a diagnostic protocol are indispensable.

Keywords: bladder pain syndrome; interstitial cystitis; multimodal therapy; treatment algorithm.

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Cystitis, Interstitial* / diagnosis
  • Cystitis, Interstitial* / therapy
  • Humans
  • Pelvic Pain
  • Taiwan
  • Urinary Bladder / pathology